PTO- 1478 |
Approved for use through 08/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90865086 |
Filing Date: 08/04/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90865086 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\908\650\90865086\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | ORUM THERAPEUTICS |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) black and orange is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the word "ORUM" with a caret symbol "^" spaced from and in overlying registration with the letter "U" of "ORUM", with the letter "R" in "ORUM" being stylized without a vertical back element, and with the word "THERAPEUTICS" being set out in reduced size letters below the word "ORUM". |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 561 x 298 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | ORUM THERAPEUTICS, INC. |
*MAILING ADDRESS | 281-25, Munji-ro, Yuseong-gu |
*CITY | Daejeon |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Korea, South |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
34050 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Korea, South |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | research and development of vaccines and medicines; drug discovery services; research on the subject of pharmaceuticals; pharmaceutical products evaluation; medical laboratory services; scientific research for medical purposes; medical research laboratory services for predicting disease; scientific investigations for medical purposes; pharmaceutical product evaluation; medical products analysis; clinical trials; biotechnology research; advisory services relating to biotechnology; development of biotechnology; biological laboratory services; biological research; development of biologics; design of biologics; research of biologics; biological surveys |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Steven J. Hultquist |
ATTORNEY DOCKET NUMBER | 4240-573 TM |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Hultquist, PLLC |
STREET | 510 Meadowmont Village Circle, PMB #363 |
CITY | Chapel Hill |
STATE | North Carolina |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 27517 |
PHONE | 919-419-9350 |
FAX | 9194199354 |
EMAIL ADDRESS | Hip@hultquistip.com |
CORRESPONDENCE INFORMATION | |
NAME | Steven J. Hultquist |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | Hip@hultquistip.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | hultquist@hultquistip.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /steven j. hultquist/ |
SIGNATORY'S NAME | Steven J. Hultquist |
SIGNATORY'S POSITION | Attorney of record, North Carolina bar member |
SIGNATORY'S PHONE NUMBER | 919-419-9350 |
DATE SIGNED | 08/04/2021 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 08/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90865086 |
Filing Date: 08/04/2021 |
The applicant's current Correspondence Information: |
Steven J. Hultquist |
PRIMARY EMAIL FOR CORRESPONDENCE: Hip@hultquistip.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): hultquist@hultquistip.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|